Example: Heart Attack

Clinical Trials on Retroperitoneal Fibrosis

Total 10 results

  • NCT04762784
    Recruiting
    A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
    Conditions: Idiopathic Retroperitoneal Fibrosis
  • NCT04762810
    Recruiting
    A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis
    Conditions: Idiopathic Retroperitoneal Fibrosis
  • NCT04047576
    Recruiting
    Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis
    Conditions: Retroperitoneal Fibrosis
  • NCT04314323
    Recruiting
    National Registry of IRPF in China
    Conditions: Idiopathic Retroperitoneal Fibrosis
  • NCT04312854
    Recruiting
    A Prospective Cohort Study of IRPF in China
    Conditions: Idiopathic Retroperitoneal Fibrosis
  • NCT02705638
    Completed
    Treatment of IgG4-Related Disease With Revlimid and Rituximab
    Conditions: Immunoglobulin G Subclass 4 Related Disease, IgG4-related Disease, Autoimmune Pancreatitis, IgG4-related Sclerosing Cholangitis, Retroperitoneal Fibrosis
  • NCT01584388
    Completed
    Rituximab in IgG4-RD: A Phase 1-2 Trial
    Conditions: Retroperitoneal Fibrosis, Autoimmune Pancreatitis, Sialadenitis, Pseudotumor
  • NCT03133949
    Unknown status
    Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria
    Conditions: Idiopathic Aortitis, Retroperitoneal Fibrosis
  • NCT01240850
    Unknown status
    Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
    Conditions: Idiopathic Retroperitoneal Fibrosis, Perianeurysmal Retroperitoneal Fibrosis, Chronic Periaortitis
  • NCT00440349
    Unknown status
    Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
    Conditions: Retroperitoneal Fibrosis
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations